Alliance Pharma plc announced that Peter Butterfield, Chief Executive Officer, is taking time away from the business for personal reasons. He is expected to return during January 2023. Andrew Franklin, Chief Financial Officer, has assumed Peter's CEO responsibilities, in line with the Group's established resilience plans, with support from the Head of Finance and the wider leadership team.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
33.74 GBX | -3.46% | +5.43% | -16.69% |
May. 09 | Alliance Pharma drops as CEO departs, delays results again | AN |
May. 08 | European Equities Close Higher in Wednesday Trading; Siemens Energy, Alliance Pharma CEOs to Step Down | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.69% | 236M | |
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+18.44% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- APH Stock
- News Alliance Pharma plc
- Alliance Pharma plc Announces CEO Changes